Bone biopsy - Medium 1-3 cm

Biopsy

Report in 288Hrs

At Home

No Fasting Required

Details

Biopsy of smaller bone lesion.

₹370₹529

30% OFF

Bone Biopsy - Medium 1-3 cm

Why is it done?
- Diagnose bone infections (osteomyelitis) by identifying bacterial, fungal, or mycobacterial pathogens through culture and histopathology
- Evaluate bone lesions and tumors including primary bone cancers (osteosarcoma, Ewing's sarcoma) and metastatic disease to confirm malignancy and determine cell type
- Assess metabolic bone disorders including osteomalacia, hyperparathyroidism, and other conditions affecting bone mineralization and architecture
- Investigate unexplained bone pain or abnormalities detected on imaging studies (X-ray, CT, or MRI) requiring tissue confirmation
- Evaluate bone marrow disorders and hematologic malignancies affecting bone structure
- Stage and grade malignancies involving bone tissue for treatment planning and prognosis determination
Normal Range
- Normal/Negative Results: - Bone tissue shows normal cellular architecture with appropriate mineralization - Normal osteocyte lacunae with appropriate spacing and density - Healthy trabecular or cortical bone structure depending on biopsy site - No evidence of malignant cells or abnormal cellular infiltration - Negative bacterial, fungal, and mycobacterial cultures - Normal marrow cellularity and composition - Absence of inflammatory infiltrates or granulomas
- Specimen Quality: - Adequate tissue quantity: 1-3 cm specimen as ordered - Adequate cellularity for evaluation - Proper fixation and decalcification for histologic examination - Representative sampling of lesion area
- Units of Measurement: - Specimen size: centimeters (cm) - Histologic findings: descriptive pathology report - Culture results: organism identification and susceptibility patterns - Bone mineral density: visual assessment of mineralization patterns
Interpretation
- Infectious Findings: - Positive cultures: identify specific organism and guide antibiotic therapy - Granulomatous inflammation: suggests tuberculosis or fungal infection - Suppurative inflammation: consistent with acute bacterial osteomyelitis - Culture susceptibility results: determine appropriate antimicrobial treatment
- Malignancy Findings: - Positive for malignancy: abnormal cells with increased mitotic activity - High-grade lesions: aggressive cellularity with marked pleomorphism - Low-grade lesions: less aggressive histologic appearance - Specific diagnosis: osteosarcoma, chondrosarcoma, Ewing's sarcoma, or metastatic disease - Immunohistochemistry results: aid in tumor classification and prognosis
- Metabolic Bone Disorder Findings: - Osteomalacia: reduced mineralization with widened osteoid seams - Hyperparathyroidism: increased osteoclastic activity and resorption - Osteoporosis: decreased bone mass with normal mineralization - Paget's disease: abnormal disorganized bone remodeling pattern
- Factors Affecting Results: - Specimen adequacy and proper orientation - Timing of biopsy in disease course - Prior treatment effects (surgery, radiation, chemotherapy) - Location of biopsy within lesion - Patient age and bone remodeling status - Chronic renal disease or metabolic factors
Associated Organs
- Primary Organ System: - Skeletal system (bones throughout the body) - Bone marrow (hematopoietic and lymphoid tissue) - Related systems affected by bone pathology
- Diseases Associated with Abnormal Results: - Osteomyelitis (bacterial, fungal, or tuberculous bone infection) - Primary bone malignancies: osteosarcoma, chondrosarcoma, Ewing's sarcoma - Metastatic bone cancer from lung, breast, prostate, kidney, or thyroid - Multiple myeloma and other hematologic malignancies - Osteomalacia and rickets - Hyperparathyroidism with bone involvement - Paget's disease of bone - Lymphomas affecting bone marrow - Granulomatous diseases (tuberculosis, histoplasmosis, coccidioidomycosis) - Chronic osteomyelitis
- Potential Complications and Risks: - Bleeding and hematoma formation at biopsy site - Infection at biopsy site (cellulitis or osteomyelitis) - Nerve or blood vessel injury depending on biopsy location - Fracture at biopsy site, particularly if bone is weakened - Persistent pain or discomfort - Allergic reaction to anesthesia - Pneumothorax if thoracic bone biopsied - Paresthesia from nerve involvement
Follow-up Tests
- Tests for Confirmed Infection: - Blood cultures (if positive, indicates bacteremia) - Complete blood count (CBC) and comprehensive metabolic panel - ESR (Erythrocyte sedimentation rate) and CRP (C-reactive protein) - Susceptibility testing from cultures to guide antibiotic selection - Follow-up imaging (CT or MRI) to assess treatment response
- Tests for Confirmed Malignancy: - Staging studies: CT chest/abdomen/pelvis and bone scan - PET scan for metastatic disease assessment - Molecular testing and cytogenetics for prognosis - Baseline chemotherapy-related labs (CBC, renal function, cardiac function) - Repeat imaging to monitor treatment response and surveillance
- Tests for Metabolic Bone Disorders: - Serum calcium, phosphate, and alkaline phosphatase levels - Parathyroid hormone (PTH) and vitamin D (25-OH and 1,25-OH) levels - 24-hour urine calcium and phosphate - Bone turnover markers (P1NP, CTX) - DEXA scan for bone mineral density assessment - Renal and hepatic function tests
- General Follow-up and Monitoring: - Repeat biopsy: only if initial results inconclusive or high clinical suspicion - Serial imaging: frequency depends on diagnosis (monthly to yearly) - Clinical reassessment: based on treatment response - Wound care evaluation: assess biopsy site healing - Laboratory monitoring: tailored to specific diagnosis and treatment
Fasting Required?
- Fasting Requirement: Yes - Required if general anesthesia will be used
- Fasting Duration: - NPO (nothing by mouth) 6-8 hours prior to procedure if general anesthesia planned - For local anesthesia only: typically no fasting required - Last clear liquid allowed 2-4 hours before procedure
- Medications to Avoid or Adjust: - Anticoagulants (warfarin, apixaban, dabigatran): hold 3-5 days prior - Antiplatelet agents (aspirin, clopidogrel): typically hold 7 days prior - NSAIDs: hold 3-7 days prior to reduce bleeding risk - Metformin: hold day of procedure if contrast used - Diabetic medications: adjust per endocrinologist or anesthesiologist - Most routine medications: take with small sip of water unless otherwise instructed
- Patient Preparation Requirements: - Signed informed consent with understanding of risks and benefits - Physical examination and pre-anesthesia clearance - Lab work: CBC, coagulation studies (PT/INR, aPTT), type and screen - Imaging review: recent X-rays, CT, or MRI of biopsy site - Remove all jewelry, dentures, hearing aids, and metal objects - Bathe or shower night before procedure - Wear loose, comfortable clothing - Arrange for adult driver if sedation used - Report all allergies, especially to medications and contrast agents - Notify provider of any active infections or fever - Discuss post-procedure activity restrictions and pain management plan

How our test process works!